Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00669383 · ClinicalTrials.gov registry record · NA
Rescue Antenatal Steroids and Pulmonary Function Tests in Preterm Infants
A NA study of Respiratory Compliance and Functional Residual Capacity, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 1
- Study location
NCT00669383 is a NA study of Respiratory Compliance and Functional Residual Capacity that has completed, run by Oregon Health and Science University. The registered enrollment target is 85 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00669383, a NA study of Respiratory Compliance and Functional Residual Capacity, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
One course of steroids given to a mother before a premature delivery helps the lungs of the premature infant and decreases breathing problems. One course of antenatal steroids is the standard of care for threatened premature deliveries. It is unclear as to how long the benefit of one course of steroids last. The most benefit to the baby's lungs seem to occur if the steroids are given at least 24 hours before but within 7 days of a premature delivery. It is difficult to predict the timing of a preterm delivery so deliveries often do not occur within this time period. We hypothesize that the benefits of the steroids to the lungs wear off if the steroids are given more than 14 days before a preterm delivery, and that in these circumstances an extra course of steroids will help the premature baby's lungs and the premature baby will have less breathing problems as shown by lung function testing.
Conditions Studied
Interventions
- DRUG placebo
- DRUG betamethasone
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2001-06 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00669383
The ClinicalTrials.gov registry entry for NCT00669383 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Respiratory Compliance appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00669383 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT00669383 about?
NCT00669383 is a clinical study titled "Rescue Antenatal Steroids and Pulmonary Function Tests in Preterm Infants". One course of steroids given to a mother before a premature delivery helps the lungs of the premature infant and decreases breathing problems. One course of antenatal steroids is the standard of care for threatened premature deliveries. It is unclear as to how long the benefit of one course of stero...
What is the current status of trial NCT00669383?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2001-06. Estimated completion is 2009-11.
What conditions does trial NCT00669383 study?
This clinical trial studies the following conditions: Respiratory Compliance, Functional Residual Capacity, Pulmonary Function Testing.
What interventions are being tested in trial NCT00669383?
The interventions under investigation include: placebo (DRUG), betamethasone (DRUG).
Who is sponsoring clinical trial NCT00669383?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00669383 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.